For Sponsors & CROs
Fewer partners. Faster starts. Data you can defend.
Sponsors are consolidating site relationships around partners who deliver repeatably instead of occasionally. Premier Bioservices gives you one contract, one set of standard operating procedures, and coordinated execution across every site in your study — with remote clinical nursing built in rather than bolted on.
- Engagement
- Single master agreement
- Startup
- Sites activated in parallel
- Reporting
- Portfolio-level visibility
- Monitoring
- Remote and centralized
Why an SMO
Site variability is the tax you keep paying.
The clinical research site market has been consolidating for a decade. Independent sites have been absorbed into multi-site networks, and sponsors have responded by narrowing their site relationships to fewer, higher-performing partners capable of consistent delivery across studies and geographies. Dedicated site networks and SMOs now represent the largest single share of the investigative site market.
The logic is simple. Every additional independent site in a study is another feasibility questionnaire, another contract negotiation, another regulatory package, another training cycle, and another set of habits that may or may not match the protocol. That variability shows up as execution risk, and execution risk shows up in your timeline.
We remove that tax by operating the network as one organization. Feasibility is centralized. Contracting is one negotiation. Startup documents are templated. Training is standardized. And the enrollment numbers you get are aggregated by us rather than assembled by you from a dozen inboxes.
What we deliver
The full site-side scope, run centrally.
Everything between protocol handover and final close-out, owned by one accountable partner.
Feasibility and site selection
Protocol read against real network capacity: patient population, investigator experience, competing studies, and where the inclusion criteria will actually bind. You get a defensible enrollment projection, not an aspirational one.
Contracting and budget negotiation
One master agreement covering the network. Budgets built from the protocol's real requirements so nothing is discovered as unfunded work in month four.
Regulatory and IRB submission
Central or local IRB submissions, delegation logs, Form FDA 1572 management, essential document collection, and an inspection-ready eISF from day one.
Coordinated startup
Sites activated in parallel against a standardized document set and training package. The tenth site starts far faster than the first because nothing is rebuilt.
Enrollment and retention delivery
Recruitment strategy agreed before activation, pre-screening against existing patient populations, and nurse-led retention contact across the follow-up window.
Remote and centralized monitoring
Risk-based oversight with pre-specified quality tolerance limits, remote source data verification, and documented escalation — the E6(R3) operating model, staffed.
Data quality and query resolution
eSource capture at the point of care, active query management, and protocol deviation documentation handled as it occurs rather than reconstructed later.
Close-out and archival
Structured close-out across every site, final query resolution, reconciliation, and a complete, retrievable trial record.
The market position
This is where sponsor behaviour has already moved.
Of sponsors report already using site networks in at least some trials, and 92% say they are likely to use them for upcoming studies.
ISR Reports, Site Networks Market Dynamics
Share of the clinical trial investigative site market held by dedicated site networks and SMOs — the largest single segment.
Credence Research, 2025
Projected global SMO market by 2030, up from roughly $6.2B in 2023, driven by outsourcing and demand for scalable site infrastructure.
Grand View Research
Good fit
We are probably worth a conversation if any of this is true.
- Your study needs more sites than your current partners can credibly activate
- A prior study in this indication missed its enrollment timeline
- The protocol has a long follow-up window and you expect retention problems
- Participants face a travel burden that will suppress visit compliance
- You need wound care, endocrine, device, or primary care patient populations
- You want remote monitoring designed in rather than retrofitted after a protocol amendment
- You are consolidating vendors and want one accountable site-side partner
- You need post-market or registry follow-up staffed for years, not months
Also relevant
Other ways we work.
Our remote clinical nursing team supports every one of these relationships. See remote and decentralized monitoring.
Start a conversation
Send us the synopsis. We will tell you honestly what the network can do.
Share a protocol synopsis or a feasibility questionnaire and we will come back with site capacity, an enrollment projection, and where we would recommend decentralized elements.